Veerappan Subramanian Ph.D. is the Chief Executive Officer of Somerset Therapeutics LLC. Veerappan is a veteran in the industry with over 50 years in the pharmaceutical business including Squibb, Johnson & Johnson, and Richardson-Merrell. After retiring from IVAX/Zenith as the Chief Scientific Officer in 1996, he has owned and operated three generic pharmaceutical companies. He is a registered pharmacist in New York and New Jersey and a Ph.D. in Pharmaceutics from Rutgers.